Exchange: NASDAQ·Updated 07:24 PM EST

About

Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534. The company was founded by David F. Hale and James B. Breitmeyer in September 1997 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Oncternal Therapeutics Inc?
What is the 52-week high for Oncternal Therapeutics Inc?
What is the 52-week low for Oncternal Therapeutics Inc?
What is Oncternal Therapeutics Inc stock price today?
What was Oncternal Therapeutics Inc stock price yesterday?
What is the 50-day moving average of Oncternal Therapeutics Inc?

Advertisement|Remove ads.